These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18848874)

  • 41. Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study.
    Wallin M; Tang P; Chang RYK; Yang M; Finlay WH; Chan HK
    BMC Pulm Med; 2019 Feb; 19(1):42. PubMed ID: 30767769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
    Learoyd TP; Burrows JL; French E; Seville PC
    Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a new inhalable thymopentin formulation.
    Wang L; Zhang Y; Tang X
    Int J Pharm; 2009 Jun; 375(1-2):1-7. PubMed ID: 19443146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treating mannitol in a saturated solution of mannitol: a novel approach to modify mannitol crystals for improved drug delivery to the lungs.
    Kaialy W; Nokhodchi A
    Int J Pharm; 2013 May; 448(1):58-70. PubMed ID: 23500603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W; Nokhodchi A
    Pharm Res; 2013 Feb; 30(2):458-77. PubMed ID: 23070603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
    van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
    Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
    Ke WR; Chang RYK; Kwok PCL; Chen D; Chan HK
    Int J Pharm; 2020 Dec; 591():119984. PubMed ID: 33069893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.
    Chew NY; Bagster DF; Chan HK
    Int J Pharm; 2000 Sep; 206(1-2):75-83. PubMed ID: 11058812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of theophylline inhalable microcomposite particles by wet milling and spray drying: The influence of mannitol as a co-milling agent.
    Malamatari M; Somavarapu S; Kachrimanis K; Bloxham M; Taylor KMG; Buckton G
    Int J Pharm; 2016 Nov; 514(1):200-211. PubMed ID: 27863663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Force control and powder dispersibility of spray dried particles for inhalation.
    Weiler C; Egen M; Trunk M; Langguth P
    J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlations between cascade impactor analysis and laser diffraction techniques for the determination of the particle size of aerosolised powder formulations.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2008 Jun; 358(1-2):75-81. PubMed ID: 18359587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
    Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Particle formation and capture during spray drying of inhalable particles.
    Mosén K; Bäckström K; Thalberg K; Schaefer T; Kristensen HG; Axelsson A
    Pharm Dev Technol; 2004 Nov; 9(4):409-17. PubMed ID: 15581077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.